Mendelsohn Aaron's Form 4 filing
Vivani Medical, Inc.VANI · filed Dec 31, 2025
- Accession no.
- 0001753926-25-002003
- Filed
- Dec 31, 2025
- Trade date
- Jul 8, 2024-Dec 29, 2025
- Filing delay
- 541 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $24.6K. It was filed 541 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mendelsohn AaronCIK 0001625195 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2024 | Common Stock | GGiftDisposed | −20,000 | $0.00 | $0 | 168,170 | Direct | |
| Dec 29, 2025 | Common Stock | PPurchaseAcquired | +20,000 | $1.23F3 | +$24,600 | 188,170 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.
Referenced by the price of 1 transaction in Table I.